Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to investigate the effect of romosozumab compared with placebo on time to radiographic healing of fresh tibial diaphyseal fractures (fractures in the midsection of the shinbone).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00907296
Study type Interventional
Source Amgen
Contact
Status Completed
Phase Phase 2
Start date September 2, 2009
Completion date May 10, 2013

See also
  Status Clinical Trial Phase
Terminated NCT00548496 - A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius Phase 2
Completed NCT03286270 - A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones
Not yet recruiting NCT04533984 - Fracture Recovery for Returning to Duty (Teriparatide STRONG) Phase 4
Recruiting NCT03232216 - Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate? N/A
Recruiting NCT04941612 - Use of the Bioabsorbable Activa IM-Nailâ„¢ in Pediatric Diaphyseal Forearm Fractures N/A
Recruiting NCT01070576 - Arginine and Nitric Oxide (NO) Early Prognostic Markers for Non-union Development N/A
Recruiting NCT05825079 - Does Weightbearing Crutch Technology Impact Patient Compliance? N/A
Completed NCT01081678 - Study To Assess FRacTure Healing With SclerosTin Antibody - Hip Phase 2
Recruiting NCT03871322 - The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures N/A
Terminated NCT00435877 - Procurement of Tissue Samples for Cell Cultures and Analyses
Completed NCT04783337 - Local Remodelling of Bone Fracture Healing N/A